Data Foundry

Drug recalls 2020

Ibuprofen 50 mg per 1 — Class II drug recall D-1067-2020

Terminated recall by Glaxosmithkline Consumer Healthcare Holdings, reported 2020-04-01, distributed nationwide. Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the

Recall numberD-1067-2020
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmGlaxosmithkline Consumer Healthcare Holdings, Warren, NJ, United States
Recall initiated2020-03-16
Classified2020-03-26
Reported by FDA2020-04-01
Terminated2021-10-28
DistributedNationwide (US)
Quantity151,056 bottles
Reason classeslabeling
NDC00573-0191, 00573-0191-20, 00573-0191-22, 00573-0191-50, 00573-0191-75
Lot numbersR73761
Model numbers0.75, 9335UA, 9336UA, F00573019150, F00573019175, F00573019175A, R56290, R60959, R74936, R78826
Expiration dates2020-03-31, 2021-01-31, 2021-02-28, 2021-11-30

Product

Ibuprofen 50 mg per 1.25 mL Oral Suspension Advil Infant Concentrated Drops White Grape 0.75 oz. and 1 oz. bottles NDC 0573-0191-75 (0.75 oz.) NDC 0573-0191-50 (1 oz.)

Reason for recall

Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1067-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.